Price (delayed)
$17.955
Market cap
$1.07B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.64
Enterprise value
$1.04B
Headquartered in Mountain View, California, IGM Biosciences is a clinical-stage biotechnology company focused on creating and developing engineered IgM antibodies. Since 2010, IGM Biosciences has worked to overcome the manufacturing
There are no recent dividends present for IGMS.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.